On Wednesday, the society called on provinces and territories to lower the colorectal cancer screening age to 45. It said people under 50 are two-to-2.5 times more likely to be diagnosed with ...

Co-occurring alterations in EGFR-mutant NSCLC are increasingly detected via broad NGS and may signal aggressive biology, prompting interest in escalation strategies that address concurrent drivers.

The evolving story of GLP-1 receptor agonists in oncology has yet another new chapter.Several studies presented at San Antonio Breast Cancer Symposium suggested the medications may help extend ...

Salspera has set out plans for a $91 million IPO to fund the phase 3 study of its bacteria-based cancer therapy. | Salspera has set out plans for a $91 million IPO to fund the phase 3 study of its ...

Vague is a word frequently used to describe symptoms of ovarian cancer. However, if there are key and persistent signs that last more than two or three weeks, it likely would be wise to see a ...

Gallbladder cancer is a challenge because of its subtle progression and its tendency to escape early detection. Although it is a relatively rare form of cancer, it is often not diagnosed until it ...

Post-diagnosis weight gain over ~1.5 years is consistently associated with increased breast cancer–specific and all-cause mortality across meta-analyses. How GLP-1 weight-loss drugs fit after breast ...

A new American Cancer Society report shows colorectal cancer is rising in younger adults. Doctors urge people at average risk start screening at age 45.

A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...

A global analysis of physical activity data from 68 countries shows large socioeconomic and gender inequalities in access to choice-based exercise, particularly active leisure. The study also ...

The results showed that 71.7% of participants preferred to prioritize maintaining QOL, compared to 8.4% who preferred to extend their survival. A majority of older patients with advanced cancer have ...